A Study of LY3502970 in Participants With Type 2 Diabetes

J2A-MC-GZGC -

The main purpose of this study is to learn more about the safety of LY3502970 and any side effects that might be associated with it. Blood tests will be done to measure how much LY3502970 is in the bloodstream, how long it takes the body to eliminate it, and how it affects blood sugar.

Trial Summary

Age Range
18 - 70 years
Conditions the trial is for
Type 2 Diabetes
What the trial is testing?
LY3502970
Could I receive a Placebo?
Yes
Enrollment Goal
68
Trial Dates
Oct 8, 2020 - Jul 12, 2021
How long will I be in the trial?
Participation could last up to 18 weeks and may include up to 14 visits (including three overnight stays) to the study center.
Trial Phase
I

Key Requirements

Clinical trials have inclusion and exclusion requirements to determine which individuals qualify for participation. Listed below are key requirements for this clinical trial, but there may be additional requirements to qualify.

Participants Must:

  • Participants must have type 2 diabetes for at least six months

  • Participants must have stable body weight for the last three months

  • Male participants must agree to use birth control during the study and for 90 days afterward and female participants must not be able to get pregnant

Participants Must Not:

  • Participants must not have type 1 diabetes

  • Participants must not have had severe low blood sugar requiring emergency treatment within the last six months

  • Participants must not have other serious or unstable illnesses

  • Participants must not take blood sugar lowering drugs, other than a stable dose of metformin

  • Participants must not be heavy alcohol drinkers or heavy cigarette smokers

Lilly Trial Alerts

Not the right fit? Sign up to receive updates about new trials that are listed or when a new trial site begins enrolling near you.